Defensins
low riskAlso: Alpha-defensins · Beta-defensins · Innate immunity peptides
Reference entry for defensins — a family of cysteine-rich antimicrobial peptides central to innate immunity. Found in neutrophils (alpha-defensins) and epithelial cells (beta-defensins). Broad-spectrum antimicrobial activity against bacteria, fungi, and viruses. Drug development interest for antibiotic-resistant infections.
Reported Benefits
Broad-spectrum antimicrobial
Well-characterized innate immunity function. Active against MRSA, Candida, HSV in vitro and in vivo.
Mechanism of Action
Cationic peptides disrupting microbial membranes via electrostatic interaction; also modulate adaptive immunity via chemotactic and dendritic cell activation functions.
Antibiotic Resistance Context
With conventional antibiotic resistance escalating, defensins and other antimicrobial peptides (AMPs) are intensively studied as alternative or adjunctive antimicrobials. Their membrane-disruption mechanism makes resistance development substantially harder than with antibiotics targeting specific metabolic pathways.
Regulatory Status
Research OnlySafety Profile
Side Effects
- •Inflammatory activation at high concentrations
Contraindications
- •Autoimmune conditions (theoretical)
Primary Uses
Related Peptides
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe Defensins?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →